Accuray | ARAY - 股本和储备



金融业
股票价格
USD
资产
USD 448.01M
现金及等价物
USD 41.3M
销售成本
USD 116.17M
流动资产
USD 292.39M
流动负债
USD 199.44M
债务
USD 170.24M
股息收益率
0
EBIT
USD 11.38M
EBITDA
USD -685K
员工
1.02K
EPS每股收益
USD 0.02
股本和储备
USD 53.42M
销售毛利
USD 41.89M
债务利息支出
USD 2.88M
贷款资金
USD 124.78M
市值
USD 28.2M
净收入
USD 2.54M
营业费用
USD 37.19M
营业利润
USD 4.71M
普通股股本
USD 100K
PE价格收益
91.13
税前利润
USD 3.23M
销售收入
USD 116.17M
销售和管理费用
USD 124.78M
股票
USD 150.96M
贸易债权人
USD 43.52M
应收帐款人
USD 91.79M


股本和储备 更改 日
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 491.69M 242K 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 435.19M 14.85M 2026-03
Surmodics USD 111.31M 7.59M 2025-06
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Trinity Biotech USD -54.72M 5.18M 2025-09